Transgenic Research

, Volume 20, Issue 5, pp 1073–1086

Epithelial cell-targeted transgene expression enables isolation of cyan fluorescent protein (CFP)-expressing prostate stem/progenitor cells

Original Paper

DOI: 10.1007/s11248-010-9478-2

Cite this article as:
Peng, W., Bao, Y. & Sawicki, J.A. Transgenic Res (2011) 20: 1073. doi:10.1007/s11248-010-9478-2


To establish a method for efficient and relatively easy isolation of a cell population containing epithelial prostate stem cells, we developed two transgenic mouse models, K5/CFP and K18/RFP. In these models, promoters of the cytokeratin 5 (Krt5) and the cytokeratin 18 (Krt18) genes regulate cyan and red fluorescent proteins (CFP and RFP), respectively. CFP and RFP reporter protein fluorescence allows for visualization of K5+ and K18+ epithelial cells within the cellular spatial context of the prostate gland and for their direct isolation by FACS. Using these models, it is possible to test directly the stem cell properties of prostate epithelial cell populations that are positively selected based on expression of cytoplasmic proteins, K5 and K18. After validating appropriate expression of the K5/CFP and K18/RFP transgenes in the developing and adult prostate, we demonstrate that a subset of CFP-expressing prostate cells exhibits stem cell proliferation potential and differentiation capabilities. Then, using prostate cells sorted from double transgenic mice (K5/CFP + K18/RFP), we compare RNA microarrays of sorted K5+K18+ basal and K5K18+ luminal epithelial cells, and identify genes that are differentially expressed. Several genes that are over-expressed in K5+ cells have previously been identified as potential stem cell markers. These results suggest that FACS isolation of prostate cells from these mice based on combining reporter gene fluorescence with expression of potential stem cell surface marker proteins will yield populations of cells enriched for stem cells to a degree that has not been attained by using cell surface markers alone.


ProstateAdult stem/progenitor cellsTransgenic miceCytokeratins

Supplementary material

11248_2010_9478_MOESM1_ESM.tif (35.5 mb)
Supplementary material 1 (TIFF 36,357 kb)
11248_2010_9478_MOESM2_ESM.tif (43.6 mb)
Supplementary material 2 (TIFF 44,634 kb)
11248_2010_9478_MOESM3_ESM.tif (30.2 mb)
Supplementary material 3 (TIFF 30,972 kb)
11248_2010_9478_MOESM4_ESM.tif (18.6 mb)
Supplementary material 4 (TIFF 19,096 kb)
11248_2010_9478_MOESM5_ESM.tif (25.5 mb)
Supplementary material 5 (TIFF 26,162 kb)
11248_2010_9478_MOESM6_ESM.tif (22.6 mb)
Supplementary material 6 (TIFF 23,177 kb)
11248_2010_9478_MOESM7_ESM.tif (21.5 mb)
Supplementary material 7 (TIFF 22,062 kb)
11248_2010_9478_MOESM8_ESM.tif (24.4 mb)
Supplementary material 8 (TIFF 24,942 kb)
11248_2010_9478_MOESM9_ESM.tif (61.4 mb)
Supplementary material 9 (TIFF 62,880 kb)
11248_2010_9478_MOESM10_ESM.doc (149 kb)
Supplementary material 10 (DOC 149 kb)
11248_2010_9478_MOESM11_ESM.doc (290 kb)
Supplementary material 11 (DOC 290 kb)
11248_2010_9478_MOESM13_ESM.doc (98 kb)
Supplementary material 13 (DOC 98 kb)
11248_2010_9478_MOESM14_ESM.doc (56 kb)
Supplementary material 14 (DOC 55 kb)

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  1. 1.Lankenau Institute for Medical ResearchWynnewoodUSA
  2. 2.Department of Dermatology and Cutaneous BiologyThomas Jefferson UniversityPhiladelphiaUSA
  3. 3.Kimmel Cancer Center, Jefferson Medical SchoolThomas Jefferson UniversityPhiladelphiaUSA